New Investigator Clinical Trials Course Faculty Dr. Spreafico is Associate Professor at the University of Toronto and Staff Medical Oncologist and Clinician-Investigator in the Department of Medical Oncology and Hematology at the Princess Margaret Cancer Centre University Health Network (PM-UHN) in Toronto, Canada. Dr. Spreafico previous trainings include: a PhD in translational research in the Program for Evaluation of Targeted Therapies (PETT) at the University of Colorado, and a subspecialty fellowship in experimental therapeutics, head and neck (HN) cancer, skin/melanoma at the Princess Margaret Cancer Centre, Toronto. Dr. Spreafico is the HN medical oncology disease site lead and Director of the Phase I Drug Development Fellowship at the Princess Margaret Cancer Centre. Dr. Spreafico is a member of the CCTG Head and Neck Disease site Executive Committee. She serves on the US NCI Head and Neck Cancer Steering Committee rare tumor task force, and she is the Co-Chair of the NRG Oncology Recurrent/Metastatic H&N Cancer Working Group.Dr. Spreafico's full-time academic practice and research include early phase clinical trials, with disease-specific interests in skin/melanoma, and head and neck cancers. Her translational research focuses on immuno-oncology-based, microbiome and cancer interception-driven studies leads as PI Canadian Cancer Trial Group, NRG and NCI CTEP early phase investigator-initiated clinical trials.
